Philip R. Lee Institute for Health Policy Studies

IHPS Research Focus
Learn more about some of the work of PRL-IHPS faculty focused on aging and dementia.

New Associate Directors for Policy
We are pleased to announce Janet Coffman, PhD, MA, MPP and Beth Griffiths, MD, MPH will be the new Philip R. Lee Institute for Health Policy Studies (PRL-IHPS), Associate Directors for Policy.
New Associate Directors for Training
We are pleased to announce Krista Harrison, PhD and Ari Hoffman, MD will be the new Philip R. Lee Institute for Health Policy Studies, Associate Directors for Training.
2021 Harold S. Luft Award Recipient
We are delighted to announce that Pamela Ling, MD, has been selected as this year's recipient of the Harold S. Luft Award for Mentoring in Health Services and Health Policy Research.
Current COVID-19 Related Research and Initiatives
IHPS faculty are responding to policy challenges raised by the COVID-19 pandemic with rapid-cycle research and technical assistance.
In Memoriam: Philip R. Lee
April 17, 1924 - October 27, 2020
View the celebration of Phil's life,
held on February 25, 2021.

Upcoming Events

Improving Access to Prescription Drugs through Policy Change
November 17th, 2021, 12-1 pm

IHPS Grand Rounds
Stacie B. Dusetzina, PhD

Associate Professor of Health Policy

Ingram Associate Professor of Cancer Research

Health Policy PhD Program Director

Vanderbilt University School of Medicine


Dr. Dusetzina is an associate professor in the Department of Health Policy and an Ingram associate professor of cancer research at Vanderbilt University School of Medicine. She is a health services researcher focusing on the intersection between health policy, epidemiology, and economics related to prescription drugs. Dr. Dusetzina’s work has contributed to the evidence base for the role of drug costs on patient access to care and policy changes that might improve patient access to high-priced drugs. She has authored or co-authored approximately 170 peer reviewed studies related to health policy and access to and use of prescription drugs.

She has been recognized for her work at a national level, including regularly engaging with the press on the topic of drug pricing and policy, co-authoring a National Academies of Sciences, Engineering and Medicine report on “Making Medicines Affordable”, and being selected to serve on the Medicare Payment Advisory Commission earlier this year.

Webinar link here

Previous Health Policy Grand Rounds


Featured Articles

Policy Opportunities To Improve Prevention, Diagnosis, And Treatment Of Perinatal Mental Health Conditions

Health Affairs

Jennifer E. Moore, Monica R. McLemore, Nadia Glenn, Kara Zivin

The scale of human suffering and economic cost associated with perinatal mental health conditions cries out for a response. Fortunately, policy options are available to address various barriers that still stand in the way of the identification and treatment of these conditions and the achievement of high-                                                                                                     quality outcomes. Policy makers should strongly                                                                                                 consider these policy options as they seek to                                                                                                      improve the US health care system and maternal                                                                                                 and child health.

                                                                                          Read more

Documentation and review of social determinants of health data in the EHR: measures and associated insights

Journal of the American Medical Informatics Association

Michael Wang, Matthew S. Pantell, Laura M. Gottlieb, Julia Adler-Milstein

In response to health systems’ efforts to better integrate medical and social data, EHRs have expanded options for documenting patients’ SDOH information. To date, there has not been a standard approach to such integration, resulting in experimentation with different documentation options and different organizational strategies to                                                                                                 promote uptake.

                                                                                          Read more

Changes in Registered Nurse Employment and Education Capacity during the COVID-19 Pandemic and the Risk of Future Shortages​​​​​​

Health Services Research

Joanne Spetz

During the first months of the COVID-19 pandemic, numerous concerns about the nursing workforce were reported. Nursing education programs have reported that their students were not able to continue their clinical education due to worries about infection risks within hospitals and some have cancelled or                                                                                               reduced entering cohorts. At the same time,                                                                                                       anecdotal reports suggested that some RNs near                                                                                               retirement chose to retire early to reduce the risk of                                                                                             infection with SARS-Cov2

                                                                                          Read more